AT
Associate Scientist
AW
Research Associate II
Get the full picture
Sign in to uncover key details.
Revitope Oncology
Blood & Organ Banks · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
700 Main St, Cambridge, Massachusetts, 0...Phone Number
(617) 500-0365Website
www.revitope.comRevenue
<$5 MillionIndustry
About Revitope Oncology
Revitope Oncology Inc. is a biotechnology company focused on developing a new class of precision cancer immunotherapies through innovative protein engineering and biological insights. Their proprietary GATE Technology Platform enables the design of bispecific antibodies that specifically target tumor cells while minimizing toxicity to healthy tissues. The company aims to address unmet needs in solid tumors by eliciting powerful immune responses directed exclusively at cancer cells. Revitope's intended clients include patients suffering from various solid cancers, as well as potential partners in the pharmaceutical industry for collaboration and development.Explore more
Revitope Oncology Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Revitope Oncology
Compare insights from companies similar to Revitope Oncology, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Revitope Oncology Tech Stack
A closer look at the technologies used by Revitope Oncology
See more technologies
Top Blood & Organ Banks Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Revitope Oncology
Sign Up For FreeTo access detailed company insights
Revitope Oncology Inc. is a biotechnology company focused on developing a new class of precision cancer immunotherapies through innovative protein engineering and biological insights. Their proprietary GATE Technology Platform enables the design of bispecific antibodies that specifically target tumor cells while minimizing toxicity to healthy tissu... Read More
